Want to join the conversation?
$ABT said that it anticipates 2016 adjusted gross margin ratio around 57%, reflecting an negative impact from exchange and partially offset by underlying gross margin improvement initiatives across it businesses. The company expects R&D investment of about 6.5% of sales in 2016 and adjusted SG&A expense of around 30.5% of sales for full year.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)